UNSPSC 51342504: Telbivudine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C10H14N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OC4HKD3SF, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-b-l-erythro-pentofuranosyl)-5-methyl- but generally known as telbivudine, which bears US NIH Compound Identifier 159269. European Medicines Agency schedules Telbivudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25231.

UNSPSC 51342504 Telbivudine is a Commodity code, yet the recent state and local opportunities posted under it do not involve telbivudine procurement at all. Instead, the sourced records capture pharmaceutical warehouse piggyback awards and naloxone procurement — neither of which aligns with the code's nominal scope of an antiviral pharmaceutical. The Illinois Department of Public Health's August 2026 award to Chartwell Rx LLC through the MMCAP Infuse consortium covered doxycycline and ciprofloxacin tablets, while Seminole County, Florida's June 2026 IFB sought naloxone and drug deactivation systems for community health initiatives. This code shows little relevant recent activity in state and local procurement and reflects a likely data-tagging misalignment between the UNSPSC taxonomy and the work agencies are actually buying.

The geographic spread of posted opportunities spans Illinois and Florida, with no additional state activity visible in the source block. The Illinois award was completed under an IFB process with a total contract value of $2,999,999.11 across three years, while Seminole County's IFB for naloxone and deactivation systems (1,900 units and 800 systems annually) carried a July 26, 2023 response deadline. Neither opportunity relates to telbivudine or its therapeutic application. Business development professionals should verify the correct UNSPSC code for pharmaceutical procurement activity of interest, as this code does not reliably surface relevant state and local solicitations.